BackOrthofix Medical Overview

Orthofix Medical Other Current Liabilities

Track Orthofix Medical's other current liabilities ($93M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Other Current Liabilities
$93.35M
↓ 6.12% YoYΔ $-6.08M vs prior year quarter

Peer trimmed avg / median

Loading

Orthofix Medical Other Current Liabilities History

Loading

Orthofix Medical vs. peers: Other Current Liabilities Comparison

Loading

Orthofix Medical Other Current Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Orthofix Medical (OFIX) FAQ

Orthofix Medical's other current liabilities stands at $93M as of June 2026. That compares with $99M in the prior-year period — down 6.1% year over year. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

Orthofix Medical reported $93M in other current liabilities versus $99M a year earlier — a 6.1% year-over-year decrease. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.

That compares with $99M in the prior-year period — down 6.1% year over year. Sustained growth in other current liabilities can support a stronger franchise, while sharp declines may reflect divestitures, weaker demand, or accounting changes. Always read YoY moves with the footnotes of recent filings in mind.

The history chart shows how Orthofix Medical's other current liabilities evolved across reporting periods, while the comparison chart places OFIX next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.

Yes — within Healthcare, other current liabilities is commonly used to spot outliers. Orthofix Medical's reading of $93M is a starting point; confirm whether differences come from growth, margins, accounting choices, or one-time items before treating an outlier as a buy or sell signal.